The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...

Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and move ...

He pushed the drill carefully through the last bit of bone. He inserted the thing using the tweezers. He sutured the hole, ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

SEATTLE — A stroke froze an Auburn man's left side until an experimental brain implant helped him regain significant fine-motor control. Matt Kidd, the first patient to enroll in a University of ...

Researchers have built a fully implantable device that sends light-based messages directly to the brain. Mice learned to interpret these artificial patterns as meaningful signals, even without touch, ...

A wireless implant that "speaks" to the brain with light could restore lost senses, say scientists. Around the size of a postage stamp and thinner than a credit card, the soft, flexible device sits ...

According to a new report by The Verge, the third experimental patient of Neuralink, Brad Smith, has decided to adopt some technologies himself to pair with his brain implant. Specifically, he chose ...

Three years after a spinal cord injury left him paralyzed from the waist down, a patient surnamed Liu has become the first person in China to receive a brain-computer interface implant billed under ...

A paralyzed man says he can now play first-person shooters like “Battlefield 6” using a Neuralink brain implant. “I can now aim with my thoughts,” wrote Rob Greiner, who is paralyzed from the ...

A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully ...

The tiny chips hitch a ride on immune cells to target inflammation in the brain. Scientists hope to kick off clinical trials within three years. From restoring movement and speech in people with ...